Acceptance, Advocacy, and Perception of Health Care Providers on COVID-19 Vaccine: Comparing Early Stage of COVID-19 Vaccination with Latter Stage in the Eastern Region of Saudi Arabia

Author:

Almusalami Eman M.1,Al-Bazroun Mohammed I.2ORCID,Alhasawi Amal I.2,Alahmed Fatimah S.2,Al-Muslim Zahra M.2,Al-Bazroun Lubana I.3,Muslim Maryam4ORCID,Saha Chandni1,Kay Elbert5,Alzahrani Zeyad A.6,Ahmed Gasmelseed Y.78ORCID,Al Mutair Abbas1491011

Affiliation:

1. Research Center, Almoosa Specialist Hospital, Al-Ahsa 36342, Saudi Arabia

2. Qatif Health Network, Qatif 32654, Saudi Arabia

3. Dhahran Eye Specialist Hospital, Dhahran 34257, Saudi Arabia

4. Almoosa College of Health Sciences, Al-Ahsa 36342, Saudi Arabia

5. Population Health Department, John Hopkins Aramco Healthcare, Al-khober 31952, Saudi Arabia

6. Administration, Presidency of State Security Hospital, Riyadh 12223, Saudi Arabia

7. Columbia University Hospital, New York, NY 10027-6907, USA

8. Faculty of Medicine and Health Sciences, Managil University for Sciences and Technology, Managil 21111, Sudan

9. School of Nursing, University of Wollongong, Wollongong 2522, Australia

10. Nursing Department, Prince Sultan Military College, Dhahran 34313, Saudi Arabia

11. Medical-Surgical Nursing Department, Princess Nourah Bint Abdulrahman University, Riyadh 84428, Saudi Arabia

Abstract

Vaccination of healthcare providers has recently gained focused attention of public health officials. As HCPs have direct contact with the population, and HCPs significantly influence the population, this study aimed to compare the acceptance rate, advocacy rate, and beliefs about the COVID-19 vaccine among HCPs in two time periods. In this repeated cross-sectional study, different HCPs were assessed in two periods ten months apart, i.e., November to December 2020 and September to October 2021, which were before and after COVID-19 vaccine approval by authorities. The study was conducted in Qatif Central Hospital, Eastern Region of Saudi Arabia. There were 609 respondents: 236 participants in the first period and 373 participants in the second period. Only 13 participants did not get the COVID-19 vaccine. There was around a 40% difference in the acceptance rate between the two study periods; the latter period was higher at 94.7%. Furthermore, 24.1% was the difference between the willingness to advocate the COVID-19 vaccine for others; the first period had a lower percentage (60.1%). Overall, results of the study showed that vaccine hesitancy, as well as the willingness to advocate for the vaccine, were improved between the pre-vaccine approval period and post-vaccine approval period, showing that the efforts made by the government improved COVID-19 acceptance and advocacy among HCPs. However, vaccine hesitancy is not a new issue, and for a better understanding of HCPs’ beliefs, a qualitative study is needed.

Publisher

MDPI AG

Subject

Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3